Cargando…
Cytochrome P-450-mediated herb and food–drug interactions can be identified in cancer patients through patient self-reporting with a tablet application: results of a prospective observational study
BACKGROUND: Consumption of herbs, food used as medicine and dietary supplements (HFDSs) is common in cancer patients. Herbs and food-drug interactions (HFDIs) can lead to serious adverse effects and can be prevented. We previously reviewed cytochrome P-450 (CYP)-mediated HFDI for 261 HFDSs and we cl...
Autores principales: | Gougis, P., Géraud, A., Hilmi, M., Vozy, A., Campedel, L., Abbar, B., Allio, C., De Chatillon, S., Portalier, A., Lapray, F., Choquet, S., Spano, J.-P., Reyal, F., Mir, O., Funck-Brentano, C., Hamy, A.-S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808458/ https://www.ncbi.nlm.nih.gov/pubmed/36493603 http://dx.doi.org/10.1016/j.esmoop.2022.100650 |
Ejemplares similares
-
Reversible Tumor Progression Induced by a Dexamethasone Course for Severe COVID-19 during Immune Checkpoint Inhibitor Treatment
por: Gougis, Paul, et al.
Publicado: (2022) -
Comparaison des caractéristiques et des pronostics des patients avec et sans cancer actif hospitalisés pour une infection à SARS-CoV-2
por: Fenioux, Charlotte, et al.
Publicado: (2021) -
Pharmacokinetic Interactions of Herbs with Cytochrome P450 and P-Glycoprotein
por: Cho, Hyun-Jong, et al.
Publicado: (2015) -
Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?
por: Gougis, Paul, et al.
Publicado: (2020) -
Modulation of Cytochrome P450, P-glycoprotein and Pregnane X Receptor by Selected Antimalarial Herbs—Implication for Herb-Drug Interaction
por: Fasinu, Pius S., et al.
Publicado: (2017)